- Home
- PSNL vs CEPF Comparison
PSNL vs CEPF Comparison
Compare PSNL & CEPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNL
- CEPF
- Stock Information
- Founded
- PSNL 2011
- CEPF 2021
- Country
- PSNL United States
- CEPF United States
- Employees
- PSNL N/A
- CEPF N/A
- Industry
- PSNL Medical Specialities
- CEPF Blank Checks
- Sector
- PSNL Health Care
- CEPF Finance
- Exchange
- PSNL Nasdaq
- CEPF Nasdaq
- Market Cap
- PSNL 518.8M
- CEPF 580.3M
- IPO Year
- PSNL 2019
- CEPF 2025
- Fundamental
- Price
- PSNL $8.68
- CEPF $10.40
- Analyst Decision
- PSNL Strong Buy
- CEPF
- Analyst Count
- PSNL 4
- CEPF 0
- Target Price
- PSNL $8.13
- CEPF N/A
- AVG Volume (30 Days)
- PSNL 931.2K
- CEPF 124.1K
- Earning Date
- PSNL 11-05-2025
- CEPF 01-01-0001
- Dividend Yield
- PSNL N/A
- CEPF N/A
- EPS Growth
- PSNL N/A
- CEPF N/A
- EPS
- PSNL N/A
- CEPF N/A
- Revenue
- PSNL $80,317,000.00
- CEPF N/A
- Revenue This Year
- PSNL N/A
- CEPF N/A
- Revenue Next Year
- PSNL $29.83
- CEPF N/A
- P/E Ratio
- PSNL N/A
- CEPF N/A
- Revenue Growth
- PSNL 0.36
- CEPF N/A
- 52 Week Low
- PSNL $2.83
- CEPF $10.09
- 52 Week High
- PSNL $8.68
- CEPF $10.65
- Technical
- Relative Strength Index (RSI)
- PSNL 78.43
- CEPF N/A
- Support Level
- PSNL $5.86
- CEPF N/A
- Resistance Level
- PSNL $7.52
- CEPF N/A
- Average True Range (ATR)
- PSNL 0.35
- CEPF 0.00
- MACD
- PSNL 0.15
- CEPF 0.00
- Stochastic Oscillator
- PSNL 98.64
- CEPF 0.00
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About CEPF Cantor Equity Partners IV Inc. Class A Ordinary Shares
Cantor Equity Partners IV Inc is a blank check company.